Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


2 Ann Hematol
4 Blood
1 Bone Marrow Transplant
1 Cancer Chemother Pharmacol
1 Gene
1 J Clin Oncol
2 J Pediatr Hematol Oncol
2 J Virol
1 Leuk Lymphoma
3 Leuk Res
1 Leukemia
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Hematol

  1. BEN LAKHAL R, Ghedira H, Bellaaj H, Ben Youssef Y, et al
    Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience).
    Ann Hematol. 2018 Jan 6. pii: 10.1007/s00277-017-3224.
    PubMed     Text format     Abstract available

  2. ZHAO H, Zhao Y, Zhang Y, Hou J, et al
    Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.
    Ann Hematol. 2017 Dec 30. pii: 10.1007/s00277-017-3216.
    PubMed     Text format     Abstract available


    LEDGF: a leukemia-specific target.
    Blood. 2018;131:4-5.
    PubMed     Text format    

  4. LOCKE FL, Anasetti C
    Off-the-shelf TCR for graft-versus-leukemia without GVHD.
    Blood. 2018;131:5-7.
    PubMed     Text format    

  5. COUTRE S, Choi M, Furman RR, Eradat H, et al
    Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy.
    Blood. 2018 Jan 5. pii: blood-2017-06-788133. doi: 10.1182/blood-2017-06-788133.
    PubMed     Text format     Abstract available

  6. BRIDE KL, Vincent TL, Im SY, Aplenc R, et al
    Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia (T-ALL).
    Blood. 2018 Jan 5. pii: blood-2017-07-794214. doi: 10.1182/blood-2017-07-794214.
    PubMed     Text format     Abstract available


  7. DYER O
    FDA panel recommends approval of first gene therapy in US.
    BMJ. 2017;358:j3443.
    PubMed     Text format    

    Bone Marrow Transplant

  8. RAMANATHAN M, Teira P, Battiwalla M, Barrett J, et al
    Impact of early CMV reactivation in cord blood stem cell recipients in the current era.
    Bone Marrow Transplant. 2016 Apr 4. doi: 10.1038/bmt.2016.
    PubMed     Text format     Abstract available

    Cancer Chemother Pharmacol

  9. KIM SY, Park JH, Yoon SY, Cho YH, et al
    A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2018 Jan 2. pii: 10.1007/s00280-017-3514.
    PubMed     Text format     Abstract available


  10. CAO S, Yang J, Qian X, Jin G, et al
    The functional polymorphisms of ARID5B and IKZF1 are associated with acute myeloid leukemia risk in a Han Chinese population.
    Gene. 2017 Dec 29. pii: S0378-1119(17)31126-5. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available

    J Clin Oncol

  11. QIAN M, Cao X, Devidas M, Yang W, et al
    TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.
    J Clin Oncol. 2018 Jan 4:JCO2017755215. doi: 10.1200/JCO.2017.75.5215.
    PubMed     Text format     Abstract available

    J Pediatr Hematol Oncol

  12. USER IR, Akbayram S, Ozokutan BH
    Clinical Presentation, Prognostic Factors, and Outcome in Neutropenic Enteropathy of Childhood Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 29. doi: 10.1097/MPH.0000000000001065.
    PubMed     Text format     Abstract available

  13. HILL R, Bricker M, Bashore L, Rapisand S, et al
    Weight Gain in Pediatric Acute Lymphoblastic Leukemia Patients With Down Syndrome.
    J Pediatr Hematol Oncol. 2017 Dec 29. doi: 10.1097/MPH.0000000000001066.
    PubMed     Text format    

    J Virol

  14. RENNER TM, Belanger K, Lam C, Gerpe MR, et al
    Full-Length Glycosylated Gag of Murine Leukemia Virus Can Associate With The Viral Envelope as a Type I Integral Membrane Protein.
    J Virol. 2018 Jan 3. pii: JVI.01530-17. doi: 10.1128/JVI.01530.
    PubMed     Text format     Abstract available

  15. NARULLA MS, Alasiri A, Charmier L, Noonan S, et al
    Erratum for Narulla et al., "Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ".
    J Virol. 2018;92.
    PubMed     Text format    

    Leuk Lymphoma

  16. CRAMER P, Fraser G, Santucci-Silva R, Grosicki S, et al
    Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in t
    Leuk Lymphoma. 2018 Jan 3:1-10. doi: 10.1080/10428194.2017.1416364.
    PubMed     Text format     Abstract available

    Leuk Res

  17. JAWOROWSKA A, Pastorczak A, Trelinska J, Wypyszczak K, et al
    Perforin gene variation influences survival in childhood acute lymphoblastic leukemia.
    Leuk Res. 2018;65:29-33.
    PubMed     Text format     Abstract available

  18. CUI P, Zhang Y, Cui M, Li Z, et al
    Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
    Leuk Res. 2018;65:49-54.
    PubMed     Text format     Abstract available

  19. KAMIJO R, Itonaga H, Kihara R, Nagata Y, et al
    Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia.
    Leuk Res. 2018;65:34-41.
    PubMed     Text format     Abstract available


  20. JO S, Lee JH, Mattei JJ, Barrett DM, et al
    Generation of a multi-antigen-directed immune response for durable control of acute lymphoblastic leukemia.
    Leukemia. 2018 Jan 5. pii: leu2017312. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

    PLoS One

  21. POHLEN M, Thoennissen NH, Braess J, Thudium J, et al
    Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction.
    PLoS One. 2018;13:e0190802.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.